Evidence that induction and suppression of mutations and recombinations by chemical mutagens in S. cerevisiae during mitosis are jointly correlated.
Mutagen-induced intergenic and interallelic recombination as well as forward mutation were studied in one and the same strain of S. cerevisiae. In nontoxic dose ranges, the induction of mutants and recombinants was parallel after treatment with ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS), N-methyl-N'-nitro-M-nitrosoguanidine (MNNG), triethylene melamine (TEM), 4-nitroquinoline 1-oxide (4-NQO), sodium nitrite (NaNO2), and 1-fluoro-2,4-dinitrobenzene (2,4-DNFB). Acridine orange (AO) after treatment without light induced recombinants, but reduced the frequency of spontaneous mutations. In combination with TEM, AO exerted the same effect, i.e., reduced its mutagenic effect and enhanced its recombinogenic effect. 4,5,6-Trichloro-2-(2,4-dichlorophenoxy) phenol (Cl5-predioxin) induced mutants and intergenic recombinants, but specifically reduced the spontaneous frequency of interallelic recombinants. In combination with TEM, it enhanced its mutagenic and intergenic recombinogenic effects but reduced its interallelic recombinogenic effect. The main conclusions of the present study, that is 1. Essentially similar lesions can lead to different genetic consequences, and 2. Induction of mutation and recombination are jointly correlated, i.e., suppression of mutations leads to an enhancement of recombinations, while suppression of recombinations leads to an enhancement of mutations, are used to set up a speculative concept for mutation and recombination induction in the diploid yeast cell during mitosis.
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology; D000165:Acridine Orange / Q000494:pharmacology; D002733:Chlorophenols / Q000494:pharmacology; D004139:Dinitrofluorobenzene / Q000494:pharmacology; D004347:Drug Interactions; D005020:Ethyl Methanesulfonate / Q000494:pharmacology; D055768:Halogenated Diphenyl Ethers; D008741:Methyl Methanesulfonate / Q000494:pharmacology; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology; D008938:Mitosis; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation / Q000187:drug effects*; D010647:Phenyl Ethers / Q000494:pharmacology; D011995:Recombination, Genetic / Q000187:drug effects*; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics*; D012977:Sodium Nitrite / Q000494:pharmacology; D014265:Triethylenemelamine / Q000494:pharmacology
D002733:Chlorophenols; D055768:Halogenated Diphenyl Ethers; D009153:Mutagens; D010647:Phenyl Ethers; D008769:Methylnitronitrosoguanidine; C012480:predioxin; D015112:4-Nitroquinoline-1-oxide; D005020:Ethyl Methanesulfonate; D008741:Methyl Methanesulfonate; D004139:Dinitrofluorobenzene; D000165:Acridine Orange; D014265:Triethylenemelamine; D012977:Sodium Nitrite